Illuminating Tumor Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Illuminating Tumor Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Illuminating Tumor Evolution Today - Breaking & Trending Today

Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation

Published: June 1, 2024

/PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address...

Source: prnewswire.com

Related Topics:

New YorkUnited StatesFabiom IwamotoAmy ConradAbi Vainstein HarasEuropean CommissionPrnewswire Sapience Therapeutics IncPresbyterian Columbia University IrvingAmerican Society Of Clinical OncologyDivision Of NeuroSapience Therapeutics IncClinical OncologyColumbia University IrvingMedical CenterPrincipal InvestigatorChief Medical OfficerClinical Science SymposiumAdvancing Trial DesignIlluminating Tumor EvolutionCentral Nervous SystemOpportunity StudySapience TherapeuticsFast TrackStabilized Peptides Engineered Against RegulationStabilized Peptides Against Receptors

Sapience Therapeutics to Showcase Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024

Published: May 23, 2024

/PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address...

Source: prnewswire.com

Related Topics:

United StatesNew YorkAmy ConradFabiom IwamotoAbi Vainstein HarasEuropean CommissionPresbyterian Columbia University IrvingAmerican Society Of Clinical OncologySapience Therapeutics IncPrnewswire Sapience Therapeutics IncDivision Of NeuroClinical OncologyChief Medical OfficerColumbia University IrvingMedical CenterPrincipal InvestigatorClinical Science SymposiumAdvancing Trial DesignIlluminating Tumor EvolutionCentral Nervous SystemOpportunity StudySapience TherapeuticsFast TrackStabilized Peptides Engineered Against RegulationStabilized Peptides Against Receptors